Abstract Details

Title TGF-beta2 Suppression by the Antisense Oligonucleotide AP 12009 as Therapy for High-Grade Glioma: Safety and Efficacy Results of Phase I/II Clinical Studies

Topic

Presentation(s)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Danielle M. Stember, MD	Dr. Stember has nothing to disclose.
Tyler Pfanner	No disclosure on file
	No disclosure on file
Richard M. Hanson, MD	No disclosure on file
	No disclosure on file
Robert Staudinger, MD, FAAN	Dr. Staudinger has nothing to disclose.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��